Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for AtriCure, Inc. (ATRC : NSDQ)
 
 • Company Description   
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.

Number of Employees: 875

 
 • Price / Volume Information   
Yesterday's Closing Price: $43.08 Daily Weekly Monthly
20 Day Moving Average: 337,340 shares
Shares Outstanding: 46.29 (millions)
Market Capitalization: $1,994.08 (millions)
Beta: 1.19
52 Week High: $89.18
52 Week Low: $38.64
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.19% -21.63%
12 Week -31.38% -27.76%
Year To Date -38.04% -27.78%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
7555 INNOVATION WAY
-
MASON,OH 45040
USA
ph: 513-755-4100
fax: 513-755-4567
lynn@gilmartinir.com http://www.atricure.com
 
 • General Corporate Information   
Officers
Michael H. Carrel - Director; President and Chief Executive Officer
B. Kristine Johnson - Chairman
Mark A. Collar - Director
Daniel P. Florin - Director
Regina E. Groves - Director

Peer Information
AtriCure, Inc. (BJCT)
AtriCure, Inc. (CADMQ)
AtriCure, Inc. (APNO)
AtriCure, Inc. (UPDC)
AtriCure, Inc. (IMTIQ)
AtriCure, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 04963C209
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 46.29
Most Recent Split Date: (:1)
Beta: 1.19
Market Capitalization: $1,994.08 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.28 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.09 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.31
Price/Cash Flow: 45.30
Price / Sales: 6.88
EPS Growth
vs. Year Ago Period: -3.13%
vs. Previous Quarter: -10.00%
Sales Growth
vs. Year Ago Period: 25.81%
vs. Previous Quarter: 1.85%
ROE
03/31/22 - -11.66
12/31/21 - -11.96
09/30/21 - -11.12
ROA
03/31/22 - -8.44
12/31/21 - -7.96
09/30/21 - -6.84
Current Ratio
03/31/22 - 4.21
12/31/21 - 3.47
09/30/21 - 3.63
Quick Ratio
03/31/22 - 3.35
12/31/21 - 2.78
09/30/21 - 2.91
Operating Margin
03/31/22 - -18.32
12/31/21 - -19.07
09/30/21 - -18.01
Net Margin
03/31/22 - 17.93
12/31/21 - 18.30
09/30/21 - 17.53
Pre-Tax Margin
03/31/22 - 18.00
12/31/21 - 18.37
09/30/21 - 17.62
Book Value
03/31/22 - 10.00
12/31/21 - 10.53
09/30/21 - 10.65
Inventory Turnover
03/31/22 - 1.87
12/31/21 - 1.81
09/30/21 - 1.78
Debt-to-Equity
03/31/22 - 0.15
12/31/21 - 0.14
09/30/21 - 0.14
Debt-to-Capital
03/31/22 - 13.09
12/31/21 - 12.61
09/30/21 - 12.01
 

Powered by Zacks Investment Research ©